ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
BankPosition in ABBV — AbbVie Inc.
CIK 109380
SALT LAKE CITY, UT
Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$10,388,705
+$2,776,773 QoQ
Shares Held
41,284
+18.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.54%
of 13F equity value
Holder Rank
#904
of 4,153 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ holds $49,893,702 across 14 Drug Manufacturers - General names. ABBV ranks #1 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
41,284 | $10,388,705 | |
| 2 | SNY |
Sanofi
|
193,917 | $8,272,499 | |
| 3 | PFE |
Pfizer Inc
|
318,425 | $7,667,674 | |
| 4 | LLY |
ELI LILLY & Co
|
5,146 | $6,172,267 | |
| 5 | MRK |
Merck & Co., Inc.
|
45,178 | $5,805,373 | |
| 6 | AMGN |
Amgen Inc
|
14,352 | $5,197,146 | |
| 7 | JNJ |
Johnson & Johnson
|
14,076 | $3,574,881 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
10,854 | $1,371,294 |
All Filings in ABBV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,388,705 | 41,284 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $7,611,932 | 34,999 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $10,099,943 | 44,203 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $13,104,700 | 56,598 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $12,263,170 | 66,066 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $12,851,118 | 61,336 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||